1. Home
  2. SRFM vs MDWD Comparison

SRFM vs MDWD Comparison

Compare SRFM & MDWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRFM
  • MDWD
  • Stock Information
  • Founded
  • SRFM 2011
  • MDWD 2000
  • Country
  • SRFM United States
  • MDWD Israel
  • Employees
  • SRFM N/A
  • MDWD N/A
  • Industry
  • SRFM Transportation Services
  • MDWD Medicinal Chemicals and Botanical Products
  • Sector
  • SRFM Consumer Discretionary
  • MDWD Health Care
  • Exchange
  • SRFM Nasdaq
  • MDWD Nasdaq
  • Market Cap
  • SRFM 185.9M
  • MDWD 208.2M
  • IPO Year
  • SRFM 2023
  • MDWD 2014
  • Fundamental
  • Price
  • SRFM $4.05
  • MDWD $16.74
  • Analyst Decision
  • SRFM Buy
  • MDWD Strong Buy
  • Analyst Count
  • SRFM 4
  • MDWD 2
  • Target Price
  • SRFM $5.75
  • MDWD $35.00
  • AVG Volume (30 Days)
  • SRFM 2.6M
  • MDWD 102.7K
  • Earning Date
  • SRFM 08-12-2025
  • MDWD 08-14-2025
  • Dividend Yield
  • SRFM N/A
  • MDWD N/A
  • EPS Growth
  • SRFM N/A
  • MDWD N/A
  • EPS
  • SRFM N/A
  • MDWD N/A
  • Revenue
  • SRFM $107,372,000.00
  • MDWD $19,858,000.00
  • Revenue This Year
  • SRFM N/A
  • MDWD $20.37
  • Revenue Next Year
  • SRFM $18.06
  • MDWD $25.91
  • P/E Ratio
  • SRFM N/A
  • MDWD N/A
  • Revenue Growth
  • SRFM N/A
  • MDWD N/A
  • 52 Week Low
  • SRFM $1.02
  • MDWD $14.14
  • 52 Week High
  • SRFM $9.91
  • MDWD $22.51
  • Technical
  • Relative Strength Index (RSI)
  • SRFM 44.49
  • MDWD 36.74
  • Support Level
  • SRFM $3.80
  • MDWD $16.29
  • Resistance Level
  • SRFM $4.97
  • MDWD $17.06
  • Average True Range (ATR)
  • SRFM 0.31
  • MDWD 0.64
  • MACD
  • SRFM -0.05
  • MDWD -0.00
  • Stochastic Oscillator
  • SRFM 21.37
  • MDWD 25.00

About SRFM Surf Air Mobility Inc.

Surf Air Mobility Inc provides a regional air mobility platform to connect communities sustainably. The company is an electric aviation and air travel company expanding the category of regional air travel and reinventing flying through electrification. The company is building a regional air mobility ecosystem to sustainably connect the world's communities. It generates revenue through air mobility services.

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Share on Social Networks: